BATS BZX Real-Time Price
As of 11:28am ET
| +0.01 / +0.30%|
The 4 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +47.49% increase from the last price of 3.39.
The current consensus among 5 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.